These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35079378)

  • 21. Effects of Autologous Cytokine-Induced Killer Cells Infusion in Colorectal Cancer Patients: A Prospective Study.
    Peng H; Yao M; Fan H; Song L; Sun J; Zhou Z; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
    Cancer Biother Radiopharm; 2017 Aug; 32(6):221-226. PubMed ID: 28820635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
    Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
    Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.
    Gao D; Li C; Xie X; Zhao P; Wei X; Sun W; Liu HC; Alexandrou AT; Jones J; Zhao R; Li JJ
    PLoS One; 2014; 9(4):e93886. PubMed ID: 24699863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma.
    Cui J; Li L; Wang C; Jin H; Yao C; Wang Y; Li D; Tian H; Niu C; Wang G; Han W; Xu J; Chen J; Li W
    Cytotherapy; 2015 Jul; 17(7):979-88. PubMed ID: 25890480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.
    Li Y; Wang C; Xu M; Kong C; Qu A; Zhang M; Zheng Z; Zhang G
    J Cancer Res Clin Oncol; 2017 May; 143(5):861-871. PubMed ID: 28108815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients.
    Zhang Y; Wang S; Yang B; Lu S; Du Y; Liu H
    Cancer Biol Med; 2019 May; 16(2):350-360. PubMed ID: 31516755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
    Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
    Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.
    Ding X; Cao H; Chen X; Jin H; Liu Z; Wang G; Cai L; Li D; Niu C; Tian H; Yang L; Zhao Y; Li W; Cui J
    J Transl Med; 2015 May; 13():158. PubMed ID: 25968637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer.
    Li DP; Li W; Feng J; Chen K; Tao M
    Oncol Res; 2015; 22(2):67-74. PubMed ID: 25706393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.
    Chang B; Shen L; Wang K; Jin J; Huang T; Chen Q; Li W; Wu P
    Liver Int; 2018 Aug; 38(8):1449-1458. PubMed ID: 29356308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis.
    Zhou X; Mo X; Qiu J; Zhao J; Wang S; Zhou C; Su Y; Lin Z; Ma H
    Cancer Manag Res; 2018; 10():5363-5372. PubMed ID: 30464632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
    Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
    Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
    Zhang J; Zhu L; Zhang Q; He X; Yin Y; Gu Y; Guo R; Lu K; Liu L; Liu P; Shu Y
    Biomed Pharmacother; 2014 Jul; 68(6):715-20. PubMed ID: 25107840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
    Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
    Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis.
    Zhao JJ; Zhou S; Chen CL; Zhang HX; Zhou ZQ; Wu ZR; Liu Y; Pan QZ; Zhu Q; Tang Y; Xia JC; Weng DS
    J Cancer; 2018; 9(22):4204-4214. PubMed ID: 30519321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer.
    Chen Y; Lin WS; Zhu WF; Lin J; Zhou ZF; Huang CZ; Chen G; Shi Y; Guo ZQ; Ye YB
    Immunol Res; 2016 Feb; 64(1):251-9. PubMed ID: 26607264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.